Hi-Risk/Recurrent/Advanced PCa Video Chat, Oct 3, 2022

Dr. John jumps in with two feet for his debut … and floats beautifully!

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 per month prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Editor’s Pick: Best comes late – beware of SELF-MEDICATING; and is a clinical trial preferable to Standard of Care? (rd)

Topics Discussed

John Birch dies – tribute next week; urinary block leads to posible denovo Mx Dx; bladder and bowel control during RT; Jevtana produces bloating; tamoxifen to address gynacomastia; dropping LHRH in daro monotherapy to address fatigue; Pluvicto preferred to CAR-T trial; switching QBs confuses decision; beware of self medicating; similarly, different man – Dr. A endorses self medication decision; should a PSMA be obtained at 0.38; clinical trial offered in lieu of SoC

Chat Log

Pat Martin (to Everyone): 5:06 PM: Thanks much. I’ll have my second infusion next Friday, so I’ll be looking out for it. Thanks

David Muslin (to Everyone): 5:21 PM: https://www.uchealth.org/provider/paul-maroni-md-urology/

George Rovder, Arlington Virginia (to Everyone): 5:26 PM: https://www.mskcc.org/nomograms/prostate

AnCan – rick (to Everyone): 5:28 PM: Telix Illucix

George Rovder, Arlington Virginia (to Everyone): 5:29 PM: https://www.appliedradiology.com/articles/fda-approves-telix-s-psma-pet-imaging-agent    genitourinary (GU) medical oncologist

Joe Gallo (to Organizer(s) Only): 5:38 PM: PSMA is much more detailed than CT and Bone scans    Although very desirable Brachy (boost) w IMRTmany RadOnc dont have experience    Sometimes it is good to vent

Frank Fabish – Columbus OH (to Everyone): 6:01 PM: Got to leave early. Thanks guys. see you next week.

George Rovder, Arlington Virginia (to Everyone): 6:10 PM: Palliative care https://www.mayoclinic.org/tests-procedures/palliative-care/about/pac-20384637

Dennis McGuire (to Everyone): 6:24 PM: Regarding Darolutamide… will Medicare approve if patient is CRPC and is metastatic ? thx

Herbert Geller (to Everyone): 6:25 PM: I am not sure, but have had trouble getting it approved.

AnCan – rick (to Everyone): 6:26 PM: Seems like it is very much up to how hard your doc fights for you.

Len Sierra (to Everyone): 6:27 PM: This is a systematic review of treatment of gynacomastia in men with PCa: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136094 The authors concluded that both RT and tamoxifen were effective, but tamoxifen was more effective.

Joe Gallo (to Everyone): 6:30 PM: Just checked. treatment to prevent gynecomastia 3 sessions radiation 12 Gy total

Mark Finn (to Everyone): 6:34 PM: got to go. Thanks for conversation.

Julian Morales – Houston (to Everyone): 6:46 PM: I see Dr E and she will engage you fully as well as monitor your condition as well as your blood work. I did go to other places but glad I found Dr. E!!!

Bob G. Philadelphia (to Everyone): 7:00 PM: Enzalutamide has 6 – 8 day half life; maybe moving right from Enza to Darolutamide, still have effects of Enza to contend with.

Harry (to Everyone): 7:00 PM: gotta go everyone. thanks for the feedback

Julian Morales – Houston (to Everyone): 7:01 PM: Need to leave. Thanks guys for another great session. see you next week. Buenos noches!

Alan Moskowitz – NJ (to Everyone): 7:01 PM: bye all

Jerry Pelfrey (to Everyone): 7:03 PM: have to leave computer is dying.

Mike Yancey-Oklahoma (to Everyone): 7:04 PM: Gotta run; early appointment tomorrow

Len Sierra (to Organizer(s) Only): 7:12 PM: Definitely.

Thomas Jacobsen – CO (to Everyone): 7:18 PM: Gotta go. Thanks to everyone for your feedback and patience with the conversation.

Bob G. Philadelphia (to Everyone): 7:26 PM: Time to go. Thanks & see you all next week. Be well.

George Rovder, Arlington Virginia (to Everyone): 7:30 PM: Thank you all. Good night.